{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:48:03Z","timestamp":1787791683327,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"University of Bern"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00198-024-07016-5","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T03:02:29Z","timestamp":1708743749000},"page":"893-902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021\u2014reversal of the secular trend?"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-3779","authenticated-orcid":false,"given":"Kurt","family":"Lippuner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Kyuchukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"key":"7016_CR1","doi-asserted-by":"publisher","unstructured":"(1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646\u2013650. https:\/\/doi.org\/10.1016\/0002-9343(93)90218-e","DOI":"10.1016\/0002-9343(93)90218-e"},{"key":"7016_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for C, Economic Aspects of O, the Committees of Scientific A, National Societies of the International Osteoporosis F (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30:3\u201344","journal-title":"Osteoporos Int"},{"key":"7016_CR3","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s00198-015-3154-6","volume":"26","author":"A Oden","year":"2015","unstructured":"Oden A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010\u20132040. Osteoporos Int 26:2243\u20132248","journal-title":"Osteoporos Int"},{"key":"7016_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bone.2007.08.026","volume":"41","author":"P Haentjens","year":"2007","unstructured":"Haentjens P, Autier P, Barette M, Venken K, Vanderschueren D, Boonen S, Hip Fracture Study G (2007) Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone 41:958\u2013964","journal-title":"Bone"},{"key":"7016_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"7016_CR6","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR et al (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267\u20132294","journal-title":"J Bone Miner Res"},{"key":"7016_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","volume":"172","author":"RP Meier","year":"2012","unstructured":"Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE (2012) Increasing occurrence of atypical femoral fractures associated with bisphosphonate use. Arch Intern Med 172:930\u2013936","journal-title":"Arch Intern Med"},{"key":"7016_CR8","first-page":"674","volume":"138","author":"N Suhm","year":"2008","unstructured":"Suhm N, Lamy O, Lippuner K (2008) Management of fragility fractures in Switzerland: results of a nationwide survey. Swiss Med Wkly 138:674\u2013683","journal-title":"Swiss Med Wkly"},{"key":"7016_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11657-022-01206-6","volume":"18","author":"K Lippuner","year":"2023","unstructured":"Lippuner K, Moghadam BY, Schwab P (2023) The osteoporosis treatment gap in Switzerland between 1998 and 2018. Arch Osteoporos 18:20","journal-title":"Arch Osteoporos"},{"key":"7016_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/BF02555245","volume":"41","author":"L Melton","year":"1987","unstructured":"Melton L, O\u2019Fallon WM, Riggs B (1987) Secular trends in the incidence of hip fractures. Calcif Tissue Int 41:57\u201364","journal-title":"Calcif Tissue Int"},{"key":"7016_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.bone.2006.12.063","volume":"40","author":"T Chevalley","year":"2007","unstructured":"Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R (2007) Incidence of hip fracture over a 10-year period (1991\u20132000): reversal of a secular trend. Bone 40:1284\u20131289","journal-title":"Bone"},{"key":"7016_CR12","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00198-008-0610-6","volume":"19","author":"E Guilley","year":"2008","unstructured":"Guilley E, Chevalley T, Herrmann F, Baccino D, Hoffmeyer P, Rapin CH, Rizzoli R (2008) Reversal of the hip fracture secular trend is related to a decrease of the incidence in institutional-dwelling elderly women. Osteoporos Int 19:1741\u20131747","journal-title":"Osteoporos Int"},{"key":"7016_CR13","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00198-022-06481-0","volume":"33","author":"K Lippuner","year":"2022","unstructured":"Lippuner K, Rimmer G, Stuck AK, Schwab P, Bock O (2022) Hospitalizations for major osteoprotic fractures in Switzerland: a long term trend analysis between 1998 and 2018. Osteoporos Int 33:2327\u20132335","journal-title":"Osteoporos Int"},{"key":"7016_CR14","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/jbmr.4821","volume":"38","author":"CW Sing","year":"2023","unstructured":"Sing CW, Lin TC, Bartholomew S et al (2023) Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. J Bone Miner Res 38:1064\u20131075","journal-title":"J Bone Miner Res"},{"key":"7016_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/jech.2003.018663","volume":"59","author":"JM Robine","year":"2005","unstructured":"Robine JM, Paccaud F (2005) Nonagenarians and centenarians in Switzerland, 1860\u20132001: a demographic analysis. J Epidemiol Community Health 59:31\u201337","journal-title":"J Epidemiol Community Health"},{"key":"7016_CR16","unstructured":"(2023) Swiss Federal Office of Statistics. Life expectancy in Switzerland. Available at https:\/\/www.bfs.admin.ch\/bfs\/de\/home\/statistiken\/bevoelkerung\/geburten-todesfaelle\/lebenserwartung.html. Last accessed July 2023"},{"key":"7016_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/eurpub\/ckac164","volume":"32","author":"L Sorrentino","year":"2022","unstructured":"Sorrentino L, Chiolero A, Carmeli C (2022) Cardiovascular mortality trends in Switzerland 1995\u20132018. Eur J Public Health 32:891\u2013893","journal-title":"Eur J Public Health"},{"key":"7016_CR18","unstructured":"(2021) Swiss Federal Office of Statistics. Plausibility of medical statistics data. Available at https:\/\/www.bfs.admin.ch\/bfs\/de\/home\/statistiken\/gesundheit\/erhebungen\/ms\/applikation-hilfe-benutzer.html#-15052091. Last accessed Novermber 2021."},{"key":"7016_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00003086-198010000-00006","volume":"152","author":"GE Lewinnek","year":"1980","unstructured":"Lewinnek GE, Kelsey J, White AA 3rd, Kreiger NJ (1980) The significance and a comparative analysis of the epidemiology of hip fractures. Clin Orthop Relat Res 152:35\u201343","journal-title":"Clin Orthop Relat Res"},{"key":"7016_CR20","unstructured":"https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/apc-aapc-tau-confidence-intervals\/average-annual-percent-change-aapc\/#Relative_Advantages_and_disadvantages_AAPC_vs_APCbookmark. Last accessed October 4th, 2023. NCIAAPCAaciAa"},{"key":"7016_CR21","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00198-008-0779-8","volume":"20","author":"K Lippuner","year":"2009","unstructured":"Lippuner K, Johansson H, Kanis JA, Rizzoli R (2009) Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 20:1131\u20131140","journal-title":"Osteoporos Int"},{"key":"7016_CR22","doi-asserted-by":"publisher","first-page":"M635","DOI":"10.1093\/gerona\/54.12.M635","volume":"54","author":"KM Fox","year":"1999","unstructured":"Fox KM, Magaziner J, Hebel JR, Kenzora JE, Kashner TM (1999) Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci 54:M635-640","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7016_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11657-021-00888-8","volume":"16","author":"M Asada","year":"2021","unstructured":"Asada M, Horii M, Ikoma K, Goto T, Okubo N, Kuriyama N, Takahashi K (2021) Hip fractures among the elderly in Kyoto, Japan: a 10-year study. Arch Osteoporos 16:30","journal-title":"Arch Osteoporos"},{"key":"7016_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M, McCloskey EV, Willers C, Borgstrom F (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16:82","journal-title":"Arch Osteoporos"},{"key":"7016_CR25","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK et al (2010) Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761\u20131771","journal-title":"N Engl J Med"},{"key":"7016_CR26","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"7016_CR27","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"DM Black","year":"1996","unstructured":"Black DM, Cummings SR, Karpf DB et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Fracture Intervention Trial Research Group. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"7016_CR28","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE et al (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296:2927\u20132938","journal-title":"JAMA"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07016-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07016-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T11:08:32Z","timestamp":1713524912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07016-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["7016"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07016-5","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,24]]},"assertion":[{"value":"28 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required by Swiss law for database analyses without individual patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have made substantial contributions to conception and design (KL, MK) and\/or analysis and interpretation of the data (MK, KL, PS, RR) and\/or important contributions to the manuscript (KL, MK, RR). All authors have seen and approved the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None (MK, PS). KL has served as an expert in advisory board meetings of Amgen Switzerland AG and UCB Pharma AG Switzerland. RR is Speaker Bureau or Scientific Advisory Board Member for Abiogen, Dairy UK, Effryx, Naturex, Nestl\u00e9, ObsEva, Theramex.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}